Altasciences acquired by Novo Holdings A/S

Feb. 2021

Client: Altasciences is the leading fully integrated early development CRO, providing a comprehensive range of services, including: Drug discovery, pre-clinical testing, clinical pharmacology and research services, and contract manufacturing (CDMO)

Role: Edgemont acted as co-advisor to Altasciences in the sale of the Company by Audax to Novo Holdings

Location: Laval, QC, Canada

Sector: Pharmaceutical Services

Lead Banker: David Blume

View Press Release

Acquired by

Get In Touch